Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
SAN DIEGO and TORONTO, March 06, 2018 -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the upcoming conferences:
- Cowen and Company 38th Annual Healthcare Conference
| Time: | 12:00 p.m. EDT | ||
| Date: | Monday, March 12, 2018 | ||
| Location: | The Boston Marriott Copley Place, Boston, MA | ||
| Live webcast: | http://wsw.com/webcast/cowen46/apto/ | ||
- 30th Annual ROTH Conference
| Time: | 9:30 a.m. PDT | ||
| Date: | Tuesday, March 13, 2018 | ||
| Location: | The Ritz Carlton, Laguna Niguel, CA | ||
| Live webcast: | http://wsw.com/webcast/roth32/apto/ | ||
- 2018 B. Riley & Co. China Healthcare Investment Partnering Symposium
| Time: | 11:30 a.m. CST (China Standard Time) | ||
| Date: | Friday, March 16, 2018 | ||
| Location: | The Intercontinental Hotel, Hangzhou, People’s Republic of China | ||
| Live webcast: | http://wsw.com/webcast/brileyco20/apto/ | ||
- Oppenheimer 28th Annual Healthcare Conference
| Time: | 8:00 a.m. EDT | ||
| Date: | Wednesday, March 21, 2018 | ||
| Location: | The Westin Grand Central, New York, NY | ||
| Live webcast: | https://veracast.com/webcasts/opco/healthcare2018/76201109497.cfm | ||
The audio webcasts can also be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live event and available for 90 days.
About Aptose Biosciences
Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. For further information, please visit www.aptose.com.
For further information, please contact:
Aptose Biosciences
Greg Chow, CFO
647-479-9828
Email: [email protected]
| SMP Communications Susan Pietropaolo 201-923-2049 [email protected] | LifeSci Advisors Michael Wood Managing Director 646-597-6983 [email protected] |
